Eligibility of Individuals With Subclinical Coronary Artery Calcium and Intermediate Coronary Heart Disease Risk for Reclassification (from the Framingham Heart Study)

American Journal of Cardiology

Volumn 103, Issue 12, 2009, Pages 1710-1715

  Preis, Sarah Rosner ^a   Hwang, Shih Jen ^a   Fox, Caroline S ^a,b   Massaro, Joseph M ^c   Levy, Daniel ^a   Hoffmann, Udo ^d   O'Donnell, Christopher J ^a,d  

^a FRAMINGHAM HEART STUDY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Boston University   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; DISEASE CLASSIFICATION; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SMOKING;

ADULT; CALCINOSIS; CALCIUM; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 67649418168     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.020     Document Type: Article

References (28)

1. Dawber T.R., Kannel W.B., and Lyell L.P. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci 107 (1963) 539-556
2. Feinleib M., Kannel W.B., Garrison R.J., McNamara P.M., and Castelli W.P. The Framingham Offspring Study. Design and preliminary data. Prev Med 4 (1975) 518-525
3. Splansky G.L., Corey D., Yang Q., Atwood L.D., Cupples L.A., Benjamin E.J., D'Agostino Sr. R.B., Fox C.S., Larson M.G., Murabito J.M., et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 165 (2007) 1328-1335
4. Hong C., Bae K.T., and Pilgram T.K. Coronary artery calcium: accuracy and reproducibility of measurements with multi-detector row CT-assessment of effects of different thresholds and quantification methods. Radiology 227 (2003) 795-801
5. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
6. Callister T.Q., Cooil B., Raya S.P., Lippolis N.J., Russo D.J., and Raggi P. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 208 (1998) 807-814
7. Hoffmann U, Massaro JM, Fox CS, Manders ES, O'Donnell CJ. Defining normal distributions of coronary artery calcification in at-risk community-based women and men: the Framingham Heart Study. Colorado Springs, CO: American Heart Association, 8 A.D.
8. Hoff J.A., Chomka E.V., Krainik A.J., Daviglus M., Rich S., and Kondos G.T. Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol 87 (2001) 1335-1339
9. McClelland R.L., Chung H., Detrano R., Post W., and Kronmal R.A. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 113 (2006) 30-37
10. Greenland P., Bonow R.O., Brundage B.H., Budoff M.J., Eisenberg M.J., Grundy S.M., Lauer M.S., Post W.S., Raggi P., Redberg R.F., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 49 (2007) 378-402
11. Budoff M.J., Achenbach S., Blumenthal R.S., Carr J.J., Goldin J.G., Greenland P., Guerci A.D., Lima J.A., Rader D.J., Rubin G.D., Shaw L.J., and Wiegers S.E. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 114 (2006) 1761-1791
12. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
13. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
14. Wilson P.W., Smith Jr. S.C., Blumenthal R.S., Burke G.L., and Wong N.D. 34th Bethesda Conference: task force #4-how do we select patients for atherosclerosis imaging?. J Am Coll Cardiol 41 (2003) 1898-1906
15. Detrano R., Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., Liu K., Shea S., Szklo M., Bluemke D.A., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358 (2008) 1336-1345
16. Taylor A.J., Bindeman J., Feuerstein I., Le T., Bauer K., Byrd C., Wu H., and O'Malley P.G. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol 51 (2008) 1337-1341
17. Shaw L.J., Raggi P., Berman D.S., and Callister T.Q. Coronary artery calcium as a measure of biologic age. Atherosclerosis 188 (2006) 112-119
18. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., and Roccella E.J. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
19. Arad Y., Goodman K.J., Roth M., Newstein D., and Guerci A.D. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 46 (2005) 158-165
20. Greenland P., LaBree L., Azen S.P., Doherty T.M., and Detrano R.C. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291 (2004) 210-215
21. Kondos G.T., Hoff J.A., Sevrukov A., Daviglus M.L., Garside D.B., Devries S.S., Chomka E.V., and Liu K. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107 (2003) 2571-2576
22. LaMonte M.J., FitzGerald S.J., Church T.S., Barlow C.E., Radford N.B., Levine B.D., Pippin J.J., Gibbons L.W., Blair S.N., and Nichaman M.Z. Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women. Am J Epidemiol 162 (2005) 421-429
23. Raggi P., Cooil B., and Callister T.Q. Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J 141 (2001) 375-382
24. Taylor A.J., Bindeman J., Feuerstein I., Cao F., Brazaitis M., and O'Malley P.G. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol 46 (2005) 807-814
25. Wong N.D., Hsu J.C., Detrano R.C., Diamond G., Eisenberg H., and Gardin J.M. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 86 (2000) 495-498
26. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto Jr. A.M., Kastelein J.J., Koenig W., Libby P., Lorenzatti A.J., MacFadyen J.G., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207
27. Kaplan N.M., Sproul L.E., and Mulcahy W.S. Large prospective study of ramipril in patients with hypertension. CARE Investigators. Clin Ther 15 (1993) 810-818
28. Dagenais G.R., Yusuf S., Bourassa M.G., Yi Q., Bosch J., Lonn E.M., Kouz S., and Grover J. Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study. Circulation 104 (2001) 522-526